Health Resources and Services Administration: HIV Care Grant Program, Part B

by: Michael Saunders

The Health Resources and Services Administration (HRSA), an agency operating within the Department of Health and Human Services, is the federal government's leading agency responsible for improving access to health care services for citizens who are uninsured, isolated or medically vulnerable.

The HRSA also been constantly working towards programs that prepare against bioterrorism, compensate individuals harmed by vaccination and maintains up to date databases that protect against health care malpractice and health care waste, fraud and abuse.

In keeping with the many health-related efforts of the HRSA, the agency has recently established a funding opportunity to support Part B of the HIV Care Grant Program which is designed to develop or improve the people's access to a comprehensive continuum of high-quality, community-based care for low-income patients diagnosed with HIV.

The HIV Care Grant Program Part B also hopes to, in accordance with the goals of the HIV/AIDS Strategy, increase access to care and treatment services and optimizing health outcomes, and reduce HIV-related health disparities.

As described in the program, a comprehensive HIV continuum of care includes:

a) outpatient and ambulatory health services

b) AIDS Drug Assistance Program (ADAP) treatments

c) AIDS pharmaceutical assistance (local)

d) oral health care

e) early intervention services
  (continued...)

Health Resources and Services Administration: HIV Care Grant Program, Part B
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

Cancer Education Grants Program
The Cancer Education Grants Program has been existent since the year 1994 and has long been providing support to innovative cancer education grants program that aim to translate the knowledge obtain from the research studies into actual public health applications.

---

Research to Advance Vaccine Safety Program
The Centers for Disease Control and Prevention has partnered with the National Institutes of Health and as a result, has developed the Research to Advance Vaccine Safety Program, wherein it seeks to obtain a more thorough understanding vaccine safety.

---